Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: A Study Of Opioid Avoidance In Surgery Through Integrating Suzetrigine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update discusses studying Suzetrigine to reduce opioid use in postoperative pain management; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suzetrigine (Suzetrigine)

Snippet

Sponsor: Mayo Clinic | Conditions: Post Operative Pain | Phase 4 | Status: NOT_YET_RECRUITING